CAMBRIDGE, Mass., Apr 30, 2012 (BUSINESS WIRE) --ARIAD
Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
webcast its presentation at the Deutsche Bank 37th Annual Health Care
Conference in Boston. Harvey J. Berger, M.D., chairman and chief
executive officer, will provide an overview of the Company's business on
Monday, May 7, 2012 at 4:10 p.m. (ET).
The ARIAD presentation at the Deutsche Bank 37th Annual Health Care
Conference will be webcast live and can be accessed by visiting the
investor relations section of the Company's website at http://www.ariad.com/investor.
A replay of the webcast presentation will also be available and archived
on the site for three weeks.
ARIAD Pharmaceuticals, Inc. is an emerging global oncology company
focused on the discovery, development and commercialization of medicines
to transform the lives of cancer patients. ARIAD's approach to
structure-based drug design has led to three internally discovered,
molecularly targeted product candidates for drug-resistant or
difficult-to-treat cancers, including certain forms of chronic myeloid
leukemia, soft tissue and bone sarcomas and non-small cell lung cancer.
For additional information, visit http://www.ariad.com
or follow ARIAD on Twitter.
SOURCE: ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc.
Cantor, (617) 621-2208
Lynn Granito, (212) 253-8881